NCT01005823View on ClinicalTrials.gov

A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Atopic Dermatitis
Interventions
DRUG

LEO 29102 cream

Twice daily application for 7 days

DRUG

LEO 29102 placebo cream

LEO 29102 placebo cream

Trial Locations (1)

Unknown

PRA International, University Medical Centre, Groningen

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY